Majority of plaintiffs reportedly back Johnson & Johnson’s proposal to settle US$6.5B talc lawsuit
15 Aug 2024 --- A secret ballot among plaintiffs reportedly shows majority support for Johnson & Johnson’s (J&J) plan to settle its outstanding talc cases.
According to Bloomberg, sources say over 75% of the group signed off on the healthcare giant’s proposal to pay US$6.5 billion over 25 years to resolve all current and future talc claims and push ahead with its bankruptcy plan.
The settlement offer apparently includes claims that the talc-based version caused ovarian and other gynecological cancers, however, J&J has said its talc-based powders never caused cancer and that it appropriately marketed its baby powder for more than 100 years.
J&J’s plan is still likely to face legal challenges from plaintiffs opposing the terms, but the recent voting could help the company if it asks a judge again to grant bankruptcy protection. A federal appeals court blocked two of its previous bids to get the bankruptcy protection sign-off in New Jersey, where the health-care company is based.
J&J’s ongoing legal battles
In May, the pharmaceutical company said it resolved 95% of claims that its baby powder was tainted with asbestos and caused mesothelioma.
J&J has maintained its products are safe, asbestos-free and do not cause cancer. In 2022, the company said it would halt sales of talc-based baby powder and transition to cornstarch-based baby powder to meet “evolving global trends.”
The company has already paid approximately US$5 billion for the talc-based powder claims, including cases related to mesothelioma, other cancers and allegations of illegal marketing by US states. J&J reports that thousands of cases may yet be filed.
In June, Personal Care Insights reported on the company’s willingness to pay US$700 million to settle an investigation brought forth by multiple US states. J&J received claimants demanding damages and medical monitoring for women who were diagnosed with cancer or who may get the disease in the future.
By Sabine Waldeck
To contact our editorial team please email us at editorial@cnsmedia.com
Subscribe now to receive the latest news directly into your inbox.
